ReNeuron Group Plc
| London Stock Exchange: RENE
ReNeuron Group Plc produces cell therapy products. It engages in the research, development, and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. The company's products include ReN001, ReN009 and ReN003. It also develops and markets stem cell lines, including ReNcell CX and ReNcell VM neural cell lines for use in academic and commercial research in non-therapeutic applications. ReNeuron Group was founded in 1997 by John David Sinden and is headquartered in Guildford, the United Kingdom.